The Global Antifreeze Proteins (AFP) Market was valued at USD 11.7 Million in 2024 and is projected to reach USD 18.7 Million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 7.0% during the forecast period (2025–2032). This growth is being driven by rising demand in medical cryopreservation, expanding applications in frozen food preservation, and accelerating investment in recombinant protein biotechnology across pharmaceutical and food processing sectors.

As the biotechnology industry transforms toward nature-inspired, sustainable biomolecular solutions, the spotlight is on the key companies who are driving innovation, scalability, and broader commercial adoption of AFP technologies. In this blog, we profile the Top 7 Companies in the Antifreeze Proteins (AFP) Industry—a mix of multinational food science corporations, biotech pioneers, and specialty biochemical firms shaping the future of cryoprotection worldwide.

---

🔟 1. Unilever

Headquarters: London, United Kingdom (Multinational)
Key Offering: Ice-Structuring Proteins (ISPs) derived from fish AFPs for frozen food applications

Unilever is the undisputed global leader in the commercial application of antifreeze proteins, holding the dominant share of the AFP market through its proprietary ice-structuring protein (ISP) technology. The company pioneered the use of fish-derived AFPs in ice cream production, dramatically improving product texture by inhibiting ice crystal growth during freeze-thaw cycles. Unilever’s AFP-based formulations are integrated across its portfolio of frozen dessert brands, representing one of the most commercially successful applications of biological cryoprotection in the food industry.

Key Initiatives:

• Proprietary recombinant production of fish-derived ISPs using yeast expression systems

• Continuous R&D investment in next-generation AFP formulations for clean-label frozen foods

• Cross-industry exploration of AFP applications in cosmetic cryoprotection and personal care

Download FREE Sample Report:
Antifreeze Proteins (AFP) Market – View in Detailed Research Report

---

9️⃣ 2. Kaneka Corporation

Headquarters: Osaka, Japan
Key Offering: Recombinant Antifreeze Proteins for pharmaceutical cryopreservation and food science

Kaneka Corporation is Japan’s foremost contributor to the AFP market and holds a significant share of the global market alongside Unilever. The company has built its AFP portfolio around pharmaceutical-grade cryopreservation solutions, targeting applications in organ preservation, stem cell banking, and biopharmaceutical cold chain management. Kaneka’s strength lies in its advanced fermentation-based production infrastructure, which enables scalable manufacturing of high-purity AFP variants suitable for medical use.

Key Initiatives:

• Strategic acquisitions and partnerships to expand cryopreservation product lines

• Investment in HEFA-compatible AFP production platforms for pharmaceutical applications

• Collaboration with Japanese research institutions on novel AFP variants from cold-adapted organisms

---

8️⃣ 3. Global Fresh Biotech

Headquarters: United States
Key Offering: Recombinant AFP products for food preservation and biomedical research

Global Fresh Biotech is a U.S.-based biotechnology company that rounds out the top-three dominant players in the AFP market. Together, Unilever, Kaneka, and Global Fresh Biotech collectively hold approximately 98% of global AFP market share as of 2024—a reflection of the industry’s highly concentrated competitive structure. Global Fresh Biotech focuses on developing and commercializing AFP variants derived from diverse organisms including fish, plants, and insects, with a strong emphasis on expanding product portfolios for both food science and biomedical markets.

Key Initiatives:

• Active development of novel AFP variants with broadened temperature range efficacy

• Partnerships with academic institutions to accelerate commercialization of innovative AFP formulations

• Focus on recombinant production using bacterial and yeast expression platforms to reduce costs

Download FREE Sample Report:
Antifreeze Proteins (AFP) Market – View in Detailed Research Report

---

7️⃣ 4. Sirona Biochem

Headquarters: Vancouver, British Columbia, Canada
Key Offering: TFC-1326 and proprietary AFP-derived compounds for cosmetic and biomedical applications

Sirona Biochem is a Canadian specialty biotech firm that has carved out a distinctive niche in the AFP space through its focus on cosmetic cryoprotection and dermatological applications. The company has developed proprietary AFP-derived compounds that demonstrate significant potential in skin care formulations designed to protect cellular integrity during cold exposure. Sirona’s approach bridges the gap between industrial biotech and consumer personal care, representing an emerging application vertical that is gaining increasing attention from cosmetics manufacturers seeking biologically inspired active ingredients.

Key Initiatives:

• Clinical-stage development of AFP-based compounds for anti-aging and cryoprotective skin care

• Licensing agreements with cosmetic ingredient manufacturers

• Research into AFP analogs with enhanced stability for topical delivery systems

---

6️⃣ 5. A/F Protein Inc.

Headquarters: Waltham, Massachusetts, USA
Key Offering: Antifreeze protein production from transgenic organisms for aquaculture and food technology

A/F Protein Inc. is a pioneering U.S. biotech company that played a foundational role in the early commercialization of antifreeze proteins, particularly through its work with transgenic aquaculture organisms. The company developed technologies to express AFP genes in commercially important fish species, enhancing their cold tolerance—a breakthrough with significant implications for aquaculture productivity in cold-climate regions. While regulatory complexities surrounding genetically engineered organisms have slowed broader deployment, A/F Protein’s scientific contributions to AFP characterization and production methodology remain highly influential within the industry.

Key Initiatives:

• Foundational R&D in transgenic AFP expression for aquaculture cold tolerance enhancement

• Intellectual property portfolio covering key AFP production and application methods

• Ongoing research into food-grade AFP applications for seafood and frozen product preservation

---

5️⃣ 6. CryoLife Inc.

Headquarters: Kennesaw, Georgia, USA
Key Offering: Cryopreservation solutions and biologics preservation technologies for cardiovascular and surgical applications

CryoLife Inc. is a well-established U.S. medical device and biologics company with a strong presence in the cryopreservation sector. While CryoLife’s primary business centers on preserved human tissues and implantable biologics for cardiovascular surgery, the company operates at a critical intersection with the AFP market through its advanced tissue preservation protocols. As AFP research demonstrates increasing viability in improving preservation outcomes for organs and tissues, CryoLife represents a strategically important end-user and potential technology adopter within the medical cryopreservation landscape.

Key Initiatives:

• Continuous innovation in cryopreservation methodologies for cardiac and vascular tissues

• Investment in next-generation preservation solutions incorporating advanced biomolecular cryoprotectants

• Partnerships with research institutions exploring AFP-enhanced protocols for improved tissue viability rates

Download FREE Sample Report:
Antifreeze Proteins (AFP) Market – View in Detailed Research Report

---

4️⃣ 7. AquaBounty Technologies

Headquarters: Maynard, Massachusetts, USA
Key Offering: Genetically engineered aquaculture products incorporating AFP gene technology

AquaBounty Technologies is best known for its development of the AquAdvantage Salmon—the first genetically engineered animal approved for human consumption in the United States. Central to the company’s genetic engineering work is the incorporation of an antifreeze protein gene derived from ocean pout, which allows the transgenic salmon to grow year-round in cold water environments. This application represents one of the most commercially realized uses of AFP gene technology in agriculture and aquaculture, making AquaBounty a noteworthy participant in the broader AFP industry landscape.

Key Initiatives:

• Commercial-scale production of AFP gene-enhanced Atlantic salmon through regulated aquaculture operations

• Expansion of land-based aquaculture facilities in North America to scale sustainable seafood production

• Ongoing engagement with regulatory bodies in multiple markets to facilitate broader approval of biotechnology-enhanced aquaculture products

Get Full Report Here:
Antifreeze Proteins (AFP) Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Antifreeze Proteins Is Broader and More Transformative Than Ever

The antifreeze proteins market is undergoing a meaningful evolution. While the industry remains highly concentrated among a small number of dominant players, the underlying science and application potential of AFPs continue to expand into new and unexpected directions. From regenerative medicine and 3D bioprinting to pharmaceutical cold chain logistics and specialty coatings, AFPs are proving to be far more versatile than their origins in frozen dessert production might suggest.

📈 Key Trends Shaping the Market:

• Rapid advances in computational protein design and machine learning-driven AFP engineering, enabling more precise and cost-effective development of novel variants

• Growing adoption of AFP technologies in pharmaceutical cold chain logistics as global vaccine distribution networks expand

• Increasing regulatory engagement in North America and Europe to streamline approval pathways for AFP-based food additives and biomedical products

• Emerging interest from the cosmetics and personal care industry in AFP-derived compounds for cryoprotective skin care formulations

• Growing investment in recombinant AFP production platforms using fermentation technologies to reduce costs and improve supply chain reliability

Get Full Report Here:
Antifreeze Proteins (AFP) Market – View in Detailed Research Report

The companies profiled above are not only advancing the science of cryoprotection—they’re pioneering the next generation of biomolecular innovation that will define cold-adaptive technology across medicine, food science, and beyond.